Literature DB >> 4604013

A multinational, double-blind trial with a new antidepressant maprotiline (Ludiomil) and amitriptyline.

B J Lauritsen, H Madsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4604013     DOI： 10.1111/j.1600-0447.1974.tb08208.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  3 in total

Review 1.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  The inherent paradox of clinical trials in psychiatry.

Authors:  H Helmchen; B Müller-Oerlinghausen
Journal:  J Med Ethics       Date:  1975-12       Impact factor: 2.903

Review 3.  Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-05       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.